Use your browser's back button to choose another title or click here for a New Search.

How to Get the Article

 Open text (html)


Bookmark and Share

Young Opioid Abusers Benefit from Extended Buprenorphine-Naloxone Treatment.

NIDA Notes 2010;23(1):8-9

Lori Whitten (NIDA Notes staff writer).

This article summarizes the outcomes of protocol CTN-0010, which found that opioid-addicted youths benefit from extended opioid maintenance therapy. In the study led by Dr. George Woody of the Delaware Valley Node of the CTN, participating 15- to 21-year olds who received drug counseling and 12 weeks of therapy with buprenorphine and naloxone abused a wide range of drugs less often than others who received only counseling and a 2-week detoxification regiment. Although buprenorphine-naloxone is an approved medication for people age 16 and over, until now clinicians have had little research to guide them on its use in teens and young adults. These CTN findings suggest that the risk of relapse following detoxification and the potential benefit of extended buprenorphine-naloxone therapy are similar in youths and adults. Extended buprenorphine-naloxone treatment is safe and effective and expands the treatment options for adolescents and young adults who are addicted to opioids, including prescription painkillers. (Newsletter article, HTML, English, 2010)

Keywords: Adolescents | Buprenorphine/Naloxone | Opioid dependence | Opioid detoxification | Pharmacological therapy | Prescription-type opiates | Suboxone | Young adults | NIDA Notes (newsletter)

Document No: 439

Submitted by the CTN Dissemination Librarians, 4/13/2010.

Whitten, Lori search
NIDA-CTN-0010 search www
Delaware Valley (Lead) search www
Mid-Atlantic search www
New England Consortium (formerly Northern New England) search www
North Carolina search www
Southwest search www

Supported by a grant from the National Institute on Drug Abuse to the University of Washington Alcohol and Drug Abuse Institute.
The materials on this site have neither been created nor reviewed by NIDA.
Updated 4/2010 --